UNAIDS report on the global AIDS epidemic shows that 2020 targets will not be met because of deeply unequal success; COVID-19 risks blowing HIV progress way off course

Missed targets have resulted in 3.5 million more HIV infections and 820 000 more AIDS-related deaths since 2015 than if the world was on track to meet the 2020 targets.

COVID-19 could affect the availability and cost of antiretroviral medicines, but the risks can be mitigated

UNAIDS study shows that the impact on production and logistics caused by COVID-19 could have a significant effect on antiretroviral therapy supply worldwide, but steps taken now could lessen the damage done

People living with HIV, TB at two to three-fold higher risk of COVID-19 death

The Western Cape has released South Africa’s first local data, which finds that although people with these common illnesses are more vulnerable to COVID-19, they are less likely to die from the new coronavirus than many previously thought.

Lockdown impacts HIV prevention programme for adolescent girls and young women

Under level 5 and 4 of South Africa’s COVID-19 lockdown regulations adolescent girls and young women (AGYW) aged 14 to 24 years could not meet face-to-face in specially created safe spaces with counsellors, as part of a combination HIV intervention programme.

How Mentor Mothers Make the Difference in Africa’s COVID-19 Hotspot

The Cape Town Metropolitan area, where mothers2mothers (m2m) is headquartered, is the epicentre of the COVID-19 pandemic in Africa.

ECHO finds no substantial difference in HIV risk among DMPA-IM, copper IUD, and LNG implant users

A pivotal clinical trial to address a long-standing question about the relationship between hormonal contraceptive use and the risk of HIV acquisition has found no substantial difference in HIV risk among 7,829 African women who were randomly assigned to use one of three highly effective methods

HIV-positive patients who take ARVs 'not at greater risk of contracting Covid-19'

South Africans who are HIV-positive and take antiretrovirals are not at greater risk of contracting Covid-19, a local expert said on Thursday.

UNAIDS welcomes new tool for HIV prevention for gay men and other men who have sex with men and transgender women

UNAIDS warmly welcomes the announcement that the long-acting injectable cabotegravir is safe and effective in preventing HIV among gay men and other men who have sex with men and transgender women.

Long-acting injectable drug prevents HIV infections

It’s not an AIDS vaccine but it may be the closest thing to one so far. A long-acting antiretroviral drug given as an injection every 2 months powerfully protected uninfected people from HIV in a large-scale study that was disrupted by the COVID-19 pandemic.